1H-Pyrrole-2,5-dione, 1-[2-(2-hydroxyethoxy)ethyl]-, 95%+, 500mg

2-Bromo-4,5-dimethoxybenzaldehyde>98.0%(GC)5g

2-Bromo-3-fluoro-4-picoline, 95.0%, 10g

(3aR,6R,6aR)-6-(tert-Butoxymethyl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 100mg

3-(4-Chloro-[1,3,5]triazin-2-yl)-benzonitrile, 95.0%, 5g

3-(Octyloxy)azetidine, 98%, 1g

2-Amino-5-chloro-4-methylpyridine, 98.0%, 1g

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 2.00 µm, 1 Piece(s)

Boc-Lysinol(Z), 95%, 10g

2-[(3,5-dichloro-4-pyridyl)methylsulfanyl]-4-methyl-1h-pyrimidin-6-one, 98%, 100mg

3-Bromo-6-(trifluoromethyl)pyridin-2-amine, 95.0%, 250mg

3,6-Di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95.0%, 10g

1-(2,6-Dichloro-phenyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester, 95.0%, 1g